loading
Castle Biosciences Inc stock is traded at $19.16, with a volume of 309.91K. It is up +1.64% in the last 24 hours and up +19.01% over the past month. Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
See More
Previous Close:
$18.85
Open:
$18.78
24h Volume:
309.91K
Relative Volume:
0.73
Market Cap:
$520.86M
Revenue:
$219.79M
Net Income/Loss:
$-57.47M
P/E Ratio:
-8.9116
EPS:
-2.15
Net Cash Flow:
$-19.25M
1W Performance:
+3.34%
1M Performance:
+19.01%
6M Performance:
-30.88%
1Y Performance:
-13.62%
1-Day Range:
Value
$18.75
$19.30
1-Week Range:
Value
$17.89
$19.30
52-Week Range:
Value
$15.45
$35.84

Castle Biosciences Inc Stock (CSTL) Company Profile

Name
Name
Castle Biosciences Inc
Name
Phone
866-788-9007
Name
Address
505 S FRIENDSWOOD DRIVE, FRIENDSWOOD, TX
Name
Employee
784
Name
Twitter
@castlebio
Name
Next Earnings Date
2024-11-04
Name
Latest SEC Filings
Name
CSTL's Discussions on Twitter

Compare CSTL with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
CSTL
Castle Biosciences Inc
19.16 520.86M 219.79M -57.47M -19.25M -2.15
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
404.37 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
197.47 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
530.50 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
117.64 34.24B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
158.58 27.64B 15.50B 1.33B 2.16B 7.34

Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-14-23 Initiated Guggenheim Buy
Jan-05-23 Initiated Scotiabank Sector Outperform
Jan-07-22 Initiated Stephens Overweight
Apr-30-21 Initiated Lake Street Buy
Nov-10-20 Initiated KeyBanc Capital Markets Overweight
Dec-27-19 Reiterated Canaccord Genuity Buy
Aug-19-19 Initiated BTIG Research Buy
Aug-19-19 Initiated Canaccord Genuity Buy
Aug-19-19 Initiated Robert W. Baird Outperform
Aug-19-19 Initiated SVB Leerink Outperform
View All

Castle Biosciences Inc Stock (CSTL) Latest News

pulisher
Jun 18, 2025

Castle Biosciences partners with SciBase for diagnostic tests - MSN

Jun 18, 2025
pulisher
Jun 17, 2025

Castle Biosciences Inc (CSTL) Stock Price Down 4.54% on Jun 17 - GuruFocus

Jun 17, 2025
pulisher
Jun 16, 2025

Castle Biosciences, SciBase Partner to Develop Predictive Tests for Skin Conditions - marketscreener.com

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences partners with SciBase for diagnostic tests (CSTL) - Seeking Alpha

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences enters collaboration, license agreement with Scibase to develop diagnostic tests for dermatologic diseases - MarketScreener

Jun 16, 2025
pulisher
Jun 16, 2025

SciBase resolves on a directed share issue of SEK 19 million and announces its intention to carry out an additional directed share issue of approximately SEK 11 million - Yahoo Finance

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences Enters Collaboration and License Agreement wi - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences (CSTL) Partners with SciBase for Dermatology Advancements | CSTL Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences partners with SciBase to develop atopic dermatitis test - Investing.com

Jun 16, 2025
pulisher
Jun 16, 2025

SciBase signs license agreement with Castle Biosciences to develop dermatology diagnostic tests - marketscreener.com

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences Enters Collaboration and License Agreement with SciBase to Develop Diagnostic Tests for Dermatologic Diseases - The Manila Times

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences Enters Collaboration and License - GlobeNewswire

Jun 16, 2025
pulisher
Jun 16, 2025

New Diagnostic Test Could Predict Atopic Dermatitis Flares Before Symptoms Appear - Stock Titan

Jun 16, 2025
pulisher
Jun 15, 2025

Castle Biosciences, Inc. (NASDAQ:CSTL) Shares Sold by Harbor Capital Advisors Inc. - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with Prestigious Lifetime Achievement Award by The American Business Awards® - Barchart.com

Jun 14, 2025
pulisher
Jun 11, 2025

Castle Biosciences' Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention | CSTL Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Castle Biosciences' Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention - The Manila Times

Jun 11, 2025
pulisher
Jun 11, 2025

Castle Biosciences’ Chief Executive Officer Derek Maetzold - GlobeNewswire

Jun 11, 2025
pulisher
Jun 11, 2025

Castle Biosciences’ Chief Executive Officer Derek Maetzold to Participate in Panel Discussion ... - Bluefield Daily Telegraph

Jun 11, 2025
pulisher
Jun 11, 2025

Castle Biosciences’ Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention - Barchart.com

Jun 11, 2025
pulisher
Jun 08, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Two Sigma Advisers LP Acquires New Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Squarepoint Ops LLC Lowers Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Castle Biosciences' Founder, President and CEO Derek Maetzold Honored with Prestigious Lifetime Achievement Award by The American Business Awards® - The Manila Times

Jun 04, 2025
pulisher
Jun 04, 2025

Castle Biosciences’ Founder, President and CEO Derek - GlobeNewswire

Jun 04, 2025
pulisher
Jun 01, 2025

ProShare Advisors LLC Makes New $230,000 Investment in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jun 01, 2025
pulisher
May 30, 2025

Castle Biosciences, Inc. (CSTL) Unveils Largest Real-World Melanoma Risk Study at ASCO 2025 - Insider Monkey

May 30, 2025
pulisher
May 29, 2025

Castle Biosciences Presents Innovative Research on Melanoma Risk Stratification at ASCO 2025 - Nasdaq

May 29, 2025
pulisher
May 29, 2025

New Data at ASCO 2025 Affirms DecisionDx®-Melanoma's - GlobeNewswire

May 29, 2025
pulisher
May 27, 2025

Castle Biosciences, Inc. (NASDAQ:CSTL) Given Consensus Rating of “Buy” by Brokerages - Defense World

May 27, 2025
pulisher
May 27, 2025

Man Group plc Buys Shares of 13,302 Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 27, 2025
pulisher
May 27, 2025

Nuveen Asset Management LLC Has $12.41 Million Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 27, 2025
pulisher
May 24, 2025

Deutsche Bank AG Buys 7,495 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 24, 2025
pulisher
May 24, 2025

Bank of America Corp DE Raises Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 24, 2025
pulisher
May 23, 2025

Castle Biosciences amends charter, stockholders vote By Investing.com - Investing.com India

May 23, 2025
pulisher
May 23, 2025

Castle Biosciences Holds Annual Stockholders Meeting - TipRanks

May 23, 2025
pulisher
May 23, 2025

Castle Biosciences amends charter, stockholders vote - Investing.com

May 23, 2025
pulisher
May 23, 2025

Some Confidence Is Lacking In Castle Biosciences, Inc. (NASDAQ:CSTL) As Shares Slide 28% - simplywall.st

May 23, 2025
pulisher
May 23, 2025

Castle Biosciences stock hits 52-week low at $15.66 By Investing.com - Investing.com Australia

May 23, 2025
pulisher
May 23, 2025

Scotiabank Issues Pessimistic Forecast for Castle Biosciences (NASDAQ:CSTL) Stock Price - Defense World

May 23, 2025
pulisher
May 21, 2025

Castle Biosciences (CSTL) Target Price Updated by Scotiabank | C - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Castle Biosciences (CSTL) Target Price Updated by Scotiabank | CSTL Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Castle Biosciences (CSTL) Price Target Revised by Scotiabank | C - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Castle Biosciences to Present at the 2025 Jefferies Global Healt - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Castle Biosciences to Present at the 2025 Jefferies Global Healthcare Conference | CSTL Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Castle Biosciences to Present at the 2025 Jefferies Global Healthcare Conference - The Manila Times

May 21, 2025
pulisher
May 21, 2025

Castle Biosciences Executive Team Reveals Strategic Updates at Jefferies Healthcare Conference - Stock Titan

May 21, 2025
pulisher
May 21, 2025

90,563 Shares in Castle Biosciences, Inc. (NASDAQ:CSTL) Purchased by D. E. Shaw & Co. Inc. - Defense World

May 21, 2025
pulisher
May 21, 2025

Ameriprise Financial Inc. Has $8.42 Million Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 21, 2025
pulisher
May 19, 2025

Northern Trust Corp Boosts Stock Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 19, 2025
pulisher
May 19, 2025

Jane Street Group LLC Reduces Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 19, 2025

Castle Biosciences Inc Stock (CSTL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Castle Biosciences Inc Stock (CSTL) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
MAETZOLD DEREK J
Pres. & Chief Exec. Officer
Apr 21 '25
Sale
21.52
1,236
26,596
74,627
MAETZOLD DEREK J
Pres. & Chief Exec. Officer
Apr 09 '25
Sale
20.22
3,647
73,739
4,440
MAETZOLD DEREK J
Pres. & Chief Exec. Officer
Apr 09 '25
Sale
20.22
1,023
20,684
75,863
MAETZOLD DEREK J
Pres. & Chief Exec. Officer
Apr 08 '25
Sale
20.03
761
15,243
4,577
MAETZOLD DEREK J
Pres. & Chief Exec. Officer
Apr 08 '25
Sale
20.03
213
4,266
76,886
diagnostics_research DGX
$179.90
price up icon 0.10%
diagnostics_research WAT
$346.80
price up icon 1.16%
diagnostics_research LH
$262.53
price up icon 0.57%
$171.87
price up icon 0.88%
diagnostics_research MTD
$1,185.18
price up icon 1.85%
diagnostics_research IQV
$158.58
price up icon 2.20%
Cap:     |  Volume (24h):